700
Participants
Start Date
March 27, 2023
Primary Completion Date
April 17, 2023
Study Completion Date
April 17, 2023
No treatment given
No treatment given
Novo Nordisk Investigational Site, Sydney
Novo Nordisk Investigational Site, Chartres
Novo Nordisk Investigational Site, Bengaluru
Novo Nordisk Investigational Site, Mexico City
Novo Nordisk Investigational Site, Riyadh
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, London
Lead Sponsor
Novo Nordisk A/S
INDUSTRY